Diagnosis and Determination of Advanced Lesions in Pancreatic Cysts Through Endoscopic Ultrasound and Cyst Fluid Analysis
Dr. Patrick Pfau presents on the role of endoscopic ultrasound and cyst fluid analysis in the evaluation of pancreas cysts. Dr. Pfau reviews risk and diagnosis of malignancy in pancreas cysts. Discover the latest up-to-date data on molecular and DNA analysis of pancreatic cyst fluid.
Interpace, Interpace Diagnostics, Interpace Biosciences, Lesions in Pancreatic, pancreatic cyst, EUS, Cyst Fluid Analysis, Diagnosis and Determination of Advanced Lesions in Pancreatic Cysts Through Endoscopic Ultrasound and Cyst Fluid Analysis, diagnosis of malignancy in pancreas cysts, pancreas cysts, PancraGen, biomarkers, molecular test, pancreaticobiliary cancer, Integrated Molecular Pathology, Patrick Pfau, Dr. Patrick Pfau, Dr Patrick Pfau, Dr. Pfau, Dr Pfau, replay, VirtualEd, pancreas and EUS, pancreatic cyst and EUS, DNA analysis of pancreatic cyst fluid, incidence of pancreatic cysts, IPMN, surgical resection of pancreatic cyst, EUS-FNA, EUS FNA, pancreatic cysts fluid DNA, pancreatic cyst fluid molecular markers, cyst fluid
Other Featured Videos
A Multidisciplinary Approach to the Management of Cholangiocarcinoma: Innovations and Insights in Diagnosis and Care
November 12, 2025
Boston Scientific EDUCARE
The complexities of cholangiocarcinoma often call for a multidisciplinary approach. Hear from this panel of experts in endoscopy, oncology, and surgery in exploring innovative treatments and current research in the management of cholangiocarcinoma. Drs. Sharma, Kundranda, and Ramanathan explore the evolving role of cholangioscopy in cancer as well as best practices in standard of care treatments.
Clinical Practice Model - PillSense™ Diagnostic Capsule for Upper Gastrointestinal Bleeding Triage and Management
April 14, 2026
ENow Solutions
A team of key opinion leaders presents a clinical practice model of PillSense™, a single-use, disposable device, that detects blood in the upper GI tract with high sensitivity and predictive value. Challenges, potential benefits, and integration of PillSense™ are considered and its use as a tool to triage patients, potentially reducing unnecessary admissions and procedures. The KOLs close with future directions of upper gastrointestinal bleeding management and an extensive Q&A discussion.
Optimizing Endobariatric Care: From Patient Selection to Long-Term Outcomes
October 7, 2026
Boston Scientific EDUCARE
Dr. Geri Keane and nurse practitioner Kristen Koller work through how to build an endobariatric program, from patient intake and ESG eligibility screening to insurance authorization, procedure preparation, recovery, and follow-up. The speakers emphasize setting realistic expectations, screening for behavioral and medical concerns, and coordinating care across clinicians, dietitians, behavioral health, and administrative staff. They review evidence for durable weight loss after ESG and highlight frequent follow-up, accessible referral pathways, and regular process reviews as keys to patient and program success.
